Principal Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
12,721
+4,004
+46% +$832K 0.04% 403
2026
Q1
$1.84M Buy
8,717
+1,303
+18% +$281K 0.03% 525
2025
Q4
$1.52M Buy
7,414
+964
+15% +$181K 0.02% 559
2025
Q3
$1.01M Buy
6,450
+488
+8% +$75.4K 0.02% 660
2025
Q2
$1M Buy
5,962
+2,474
+71% +$367K 0.02% 615
2025
Q1
$412K Hold
3,488
0.01% 852
2024
Q4
$412K Sell
3,488
-5,562
-61% -$649K 0.01% 845
2024
Q3
$1M Buy
9,050
+396
+5% +$41.4K 0.02% 528
2024
Q2
$851K Buy
8,654
+5,696
+193% +$580K 0.02% 521
2024
Q1
$331K Buy
2,958
+969
+49% +$105K 0.01% 827
2023
Q4
$201K Buy
+1,989
New +$197K 0.01% 932

Other funds holding CAH

Principal Securities's CAH Position: Q2 2026 in Review

Principal Securities increased its Cardinal Health (CAH) stake by 46% in Q2 2026, buying an estimated $832K and bringing the position to 12,721 shares worth $3.02M. The position accounts for 0.04% of the portfolio, ranked #403.

Principal Securities first reported a position in CAH in Q4 2023 and has held it in 11 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Principal Securities held 12,721 shares of Cardinal Health worth $3.02M as of Q2 2026.
  • Principal Securities bought 4,004 Cardinal Health shares in Q2 2026, an estimated $832K.
  • Cardinal Health made up 0.04% of Principal Securities's portfolio in Q2 2026, its #403 holding.
  • Principal Securities first reported a position in Cardinal Health in Q4 2023 and has held it in 11 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.